EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols

Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch

Inflammopharmacology · 2024

DOI: 10.1007/s10787-024-01483-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Abdul Mannan Baig und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany. AbdulMannan.Baig@clinicum-stgeorg.de. Hauptthemen laut MEDLINE: COVID-19, Post-Acute COVID-19 Syndrome, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long COVID, now unmistakably identified as a syndromic entity encompassing a complex spectrum of symptoms, demands immediate resolution of its elusive pathogenic underpinnings. The intricate interplay of diverse factors presents a complex puzzle, difficult to resolve, and thus poses a substantial challenge. As instances of long COVID manifest by repeated infections of SARS-CoV-2 and genetic predisposition, a detailed understanding in this regard is needed. This endeavor is a comprehensive exploration and analysis of the cascading pathogenetic events driven by viral persistence and replication. Beyond its morbidity, long COVID, more disabling than fatal, exacts one of the most substantial tolls on public health in contemporary times, with the potential to cripple national economies. The paper introduces a unified theory of long COVID, detailing a novel pathophysiological framework that interlinks persistent SARS-CoV-2 infection, autoimmunity, and systemic vascular pathology. We posit a model where viral reservoirs, immune dysregulation, and genetic predispositions converge to perpetuate disease. It challenges prevailing hypotheses with new evidence, suggesting innovative diagnostic and therapeutic approaches. The paper aims to shift the paradigm in long COVID research by providing an integrative perspective that encapsulates the multifaceted nature of the condition. We explain the immunological mechanisms, hypercoagulability states, and viral reservoirs in the skull that feed NeuroCOVID in patients with long COVID. Also, this study hints toward a patient approach and how to prioritize treatment sequences in long COVID patients in hospitals and clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Post-Acute COVID-19 SyndromeSARS-CoV-2HumansGenetic Predisposition to DiseaseCOVID-19 Drug TreatmentAutoimmunity

Stichwörter der Autor:innen

AutoimmunityCOVID-19Long COVIDMulti-System InflammationNeuroCOVIDSARS-CoV-2Spike ProteinViral Persistence

Autor:innen und Institutionen

  • Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany. AbdulMannan.Baig@clinicum-stgeorg.de.
  • Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany.

Zitieren

APA

Baig, A. M., Rosko, S., Jaeger, B., Gerlach, J., & Rausch, H. (2024). Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01483-2

Vancouver

Baig AM, Rosko S, Jaeger B, Gerlach J, Rausch H. Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01483-2

BibTeX
@article{Baig2024,
  author = {Baig, Abdul Mannan and Rosko, Sandy and Jaeger, Beate and Gerlach, Joachim and Rausch, Hans},
  title = {Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols},
  journal = {Inflammopharmacology},
  year = {2024},
  doi = {10.1007/s10787-024-01483-2}
}
Kostenlos starten →